COLLPLANT HOLDI / S (NASDAQ: CLGN) is one of 28 public companies in the Surgery and Consumables sector, but how does it contrast with your peers? We compare COLLPLANT HOLDI / S with similar businesses based on risk, profitability, earnings, analysts' recommendations, institutional ownership, dividends and awards.
This is a breakdown of COLLPLANT HOLDI / S's recent ratings and colleagues, as MarketBeat.com reports.
|We sell ratings||Keep an evaluation||Buy Review||Strong evaluation of purchases||Score scores|
|COLLPLANT HOLDI / S||0||0||0||0||ON|
|Contestant COLLPLANT HOLDI / S||177||826||1457||73||2.56|
The Group of Surgical Appliances and Consumables has a potential growth of 21.48%. As COLLPLANT HOLDI / S colleagues are probably higher, analysts clearly believe that COLLPLANT HOLDI / S has less favorable growth prospects than its colleagues.
Insider and institutional ownership
57.9% shares of all companies "Surgical Appliances and Consumables" are owned by institutional investors. 10.3% of the shares of all companies "Surgical Appliances and Supplies" are owned by the company's foreign investors. Strong institutional ownership means that hedge funds, subsidies and big financial managers believe that equity assets will outperform in the long run.
Profit and Valuation
This table compares COLLPLANT HOLDI / S and its top-line earnings, earnings per share and awards.
|gross income||Net income||Price / Profit Ratio|
|COLLPLANT HOLDI / S||$ 480,000.00||– $ 6.02 million||-2.33|
|Contestant COLLPLANT HOLDI / S||$ 1.33 billion||$ 201.40 million||20.72|
COLLPLANT HOLDI / S has higher revenues and revenues than COLLPLANT HOLDI / S. COLLPLANT HOLDI / S is traded at lower prices than its associates, which suggests that it is currently more cost-effective than other companies in its business.
This table is compared by COLLPLANT HOLDI / S and its net margins, return on equity and return on assets.
|Clean edges||Return on equity||Return on assets|
|COLLPLANT HOLDI / S||-552.97%||-80,17%||-41.81%|
|Contestant COLLPLANT HOLDI / S||-141.13%||-195,47%||-22,59%|
COLLPLANT HOLDI / S players COLLPLANT HOLDI / S for 8 out of 9 compared factors.
About COLLPLANT HOLDI / S
CollPlant Holdings Ltd., a company dedicated to regenerative medicine, focuses on the development and commercialization of tissue repair products for three-dimensional biopreparation of tissues and organs, orthobiology and advanced wound care markets in the United States, Canada and Europe. Its products are based on recombinant human collagen type I (rhCollagen), which is produced with its own patented genetic engineering technology. The company's products include Vergenix STR, a soft tissue repair matrix designed to treat tendinopathy; Vergenix FG, a wound filling gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores and other chronic wounds; and BioInks for 3D print tissues and organs. CollPlant Holdings Ltd. based in Ness Zion, Israel.
Get news and ratings for COLLPLANT HOLDI / S Daily – Enter your email address below and get a brief daily summary of COLLPLANT HOLDI / S analysts 'latest analysts' and analyst reports and a company associated with MarketBeat.com e-mail newsletter for FREE.